Digital Health Outcomes at European ISPOR in Milan

· · Leave a Reply

ispor-milan-2016

 

Digital Health Outcomes presented publicly services and technologies at ISPOR 2016 in Milan. We’d like to thank all our partners for support and ongoing collaboration. We look forward for new opportunities in 2016 !

During a 3 day conference were were exposed to a lot of interest from the side of pharmaceutical producers and consulting sector. A lot of conference participants were interested in a new approaches to data visualisations and interactive storytelling. We appreciate the dataviz movement is growing within a healthcare  and life sciences industries. Effective data communications is a crucial step in market access. Pharmaceutical producers spend millions of dollars to develop robust and strong clinical evidence, but don’t communicate findings in the most effective manner. Our role and goal is to power credible data with modern data visulaizaion appraoces tools and libraries to convey health evidence in the most effective way.

Big Data hype or how not to get into a trap

· · Leave a Reply

The ‘big data’ matter has lately been widely discussed within the various businesses and industries, such as IT,  chemical, pharmaceutical, metallurgical, financial, oil and gas, consumer, high technology, retail etc. No wonder it even managed to create a significant hype, the promises of big data acquisitions are very tempting, but the failure rate is high as well.

We tried to analyze different researches regarding ‘big data’ and form our own opinion on the subject.

Read More

Budget Impact Model app for iPad and Web – an effective tool for payer engagement

· · 1 Reply

iPad budget impact model apps – communication tools for engagement with payers and prescribers

Live tool example

Budget Impact Model (BIM) is the health economics type of model which calculates the net cost of including a new drug or therapy into certain healthcare system or payer, hospital settings. Budget impact model app (budget impact analysis) quantifies the financial impact of a new therapy (drug, medical device, vaccine) for a decision maker (payer), thus allowing pharmaceutical and medical device companies to clearly and persuasively communicate the product cost and clinical value. It is accomplished through measuring the net cumulative cost of particular drug or therapy for a specific number of patients, with at least two (including and excluding the product in question) comparative scenarios.

Read More

Digital Health Outcomes at ISPOR EU 2014

· · Leave a Reply

Before ISPOR was always a scientific event for us, now it becomes more of a communication and networking event. We met many companies and promoted our key commercial and scientific work streams:

  • web and iPad health economics models
  • value communication content management solutions for market access
  • social media listening, insights, data mining and analytics

Read More

Why economic evaluation of health and healthcare is different from traditional goods and services?

· · Leave a Reply

We raise the question of difference between economic evaluation of health and traditional goods and services because healthcare market is conceptually different, thus requires different approach to evaluation.

This issue has been catching attention of many economists for the past decades. One of the most notable among them is 1963 Nobel Prize winner Kenneth Arrow[1] and his work “Uncertainty and the welfare economics of medical care”. Despite the fact that more than forty years passed since the publication – it still remains actual and of current interest.

Read More

Why eDetailing is an effective way to communicate your value story?

· · 2 Replies

Usually when sales rep has a meeting with doctor, payer or provider, the time frame is very tight. It is a matter of minutes for the rep to bring the key message to a target audience. It is important to spend the time rationally and present the core idea alongside strong arguments, while being as laconic as possible.

However, this does not mean that the presentation shouldn’t contain supplementary information and specific details the payer might potentially be interested in. It should, together with evidence for all possible answers for the questions that may occur. In other words, the rep must be ready to be as precise and informative, as the audience requests.

Read More

An engine for automatic transformation of Excel models to JavaScript

· · Leave a Reply

A few years ago Digital Health Outcomes faced a need to develop an engine core which would be able to automatically transform Excel models with all their logic, formulas and dependencies to JavaScript. The reasoning was simple: instead of doing the whole transformation process every time for each model, it was enough to write the core once and then use it for all the subsequent case, thus significantly reducing development time.

The goal was clear and the challenge was accepted.

Read More

Digital Technologies in Healthcare and obstacles to their adoption in large organisations

· · Leave a Reply

In the current age of rapidly developing informational technologies they are literally impacting more and more spheres of social life, and Healthcare has not been an exception. Such notions as Digital Marketing and eDetailing have infiltrated pharmaceutical and life science industries long ago and reliably anchored within. This process quickly included the products of fast growing market of mobile/tablet devices and other gadgets. Thus, new user-friendly application development opportunities were discovered, often accompanied by cloud-based technologies, which are globally accessible and synched.

Read More

What are the Advantages of Web Based Health Economics Models for Devices Market Access ?

· · Leave a Reply

Despite the prevailing trend of “consumerization of information technologies”, many mathematical models in various industries (life science, financial, R&D etc.) remains Excel-based. Yet a few years ago, IT was mostly associated with technical specialists – people with sufficient software/hardware knowledge and skills, but recently IT has become more accessible and easy to use for wider audience. Thus, removing main barriers for transformation of mathematical models (health economics, financial, etc) into a more interactive and customer-oriented form with much wider scope for development and customization.

Needless to say, custom development, as against traditional Excel, also enables new presentation layer options, which usually take the form of nice looking and interactive dashboards, while model inputs are done in the form of interactive sliders, drop boxes, radio buttons, checkboxes etc.

Read More